fludarabine has been researched along with lysophosphatidic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gibson, SB; Haney, N; Hu, X; Johnston, JB; Kabore, AF; Kropp, D | 1 |
Banerji, V; Gibson, SB; Hu, X; Johnston, JB; Mendoza, FJ; Sun, J | 1 |
Brown, M; Gibson, SB; Hernandez, TA; Hu, X; Johnston, JB; Kumar, SA; Kuschak, B | 1 |
3 other study(ies) available for fludarabine and lysophosphatidic acid
Article | Year |
---|---|
Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia cells from apoptosis through LPA receptor activation of the anti-apoptotic protein AKT/PKB.
Topics: Apoptosis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Lysophospholipids; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Lysophosphatidic Acid; Tumor Cells, Cultured; Vidarabine | 2005 |
Lysophosphatidic acid (LPA) induces the expression of VEGF leading to protection against apoptosis in B-cell derived malignancies.
Topics: Apoptosis; Burkitt Lymphoma; Cell Line, Tumor; Gene Expression; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoproliferative Disorders; Lysophospholipids; Multiple Myeloma; Mutagens; NF-kappa B; RNA, Messenger; Vascular Endothelial Growth Factor A; Vidarabine | 2008 |
Lysophosphatidic acid receptor expression in chronic lymphocytic leukemia leads to cell survival mediated though vascular endothelial growth factor expression.
Topics: Aged; Aged, 80 and over; Apoptosis; Cell Line, Tumor; Cell Survival; Cells, Cultured; Female; Gene Expression Profiling; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lysophospholipids; Male; Middle Aged; Receptors, Lysophosphatidic Acid; Receptors, Purinergic P2; Receptors, Vascular Endothelial Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Vascular Endothelial Growth Factor A; Vidarabine | 2009 |